glp-1 drugs sleep apnea and Weight-loss drug approved to treat
Description
Chollet, F
By understanding the intricate role of GLP-1 and leveraging the vast potential of botanical extracts like berberine, bitter melon, green tea EGCG, and mulberry leaf DNJ, we can unlock new avenues for maintaining metabolic balance
Glucagon-like peptide-1 receptor agonist treatment with semaglutide in type 1 diabetes
In addition to acting on neuronal cells, GLP-1R agonists also exert effects on microglia and astrocytes through cAMP/PKA signaling pathway
Diabetes 17 , e70063 (2025)
Tirzepatide was FDA-approved for T2D in 2022, and showed impressive weight reductions in subsequent obesity trials
